Professional
Added to YB: 2026-05-18
Pitch date: 2026-05-11
QDEL [bullish]
QuidelOrtho Corporation
+13.12%
current return
Author Info
No bio for this author
Company Info
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Market Cap
$753.5M
Pitch Price
$10.06
Price Target
80.00 (+603%)
Dividend
N/A
EV/EBITDA
6.49
P/E
-0.62
EV/Sales
1.31
Sector
Health Care Equipment and Supplies
Category
value
McIntyre Partnerships New Position: QuidelOrtho Corporation
QDEL (new position): Healthcare diagnostics co w/ razor/razorblade model, 95% consumables, 5-7yr contracts, >95% renewal rate. Core labs/immunohematology (75% sales) growing 6%, expect $2.2B rev & 25% EBITDA margin in 2027 = $550M EBITDA, $250M ulFCF. Trading 6x EV/EBITDA vs peers >10x. 5 issues (COVID decline, ERP A/R, weak flu season, China reimbursement cut, LEX launch drag) are unrelated/temporary. $4 FCF/sh 2028 est, 15-20x PE peers → $60-80 PT (97% IRR). 4x levered but manageable, debt to 2030, levers incl $1.7B immunohematology sale value.
Read full article (13 min)